blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3753564

EP3753564 - APPLICATION OF (5R)-5-HYDROXYTRIPTOLIDE IN PREPARATION OF DRUGS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  06.10.2023
Database last updated on 02.09.2024
FormerRequest for examination was made
Status updated on  20.11.2020
FormerThe international publication has been made
Status updated on  24.08.2019
Most recent event   Tooltip02.02.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Peking Union Medical College Hospital
No.1 Shuaifu Garden, Wangfujing
Dongcheng District
Beijing 100000 / CN
For all designated states
Shanghai Pharmaceuticals Holding Co., Ltd.
No. 92 Zhangjiang Road
Pudong New Area
Shanghai 201203 / CN
[2020/52]
Inventor(s)01 / LI, Taisheng
No. 92 Zhangjiang Road, Pudong New Area
Shanghai 201203 / CN
02 / LIU, Yanjun
No. 92 Zhangjiang Road, Pudong New Area
Shanghai 201203 / CN
 [2020/52]
Representative(s)Gulde & Partner
Patent- und Rechtsanwaltskanzlei mbB
Wallstraße 58/59
10179 Berlin / DE
[2020/52]
Application number, filing date18906500.614.12.2018
[2020/52]
WO2018CN121201
Priority number, dateCN20181014914913.02.2018         Original published format: CN201810149149
[2020/52]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019157854
Date:22.08.2019
Language:ZH
[2019/34]
Type: A1 Application with search report 
No.:EP3753564
Date:23.12.2020
Language:EN
[2020/52]
Search report(s)International search report - published on:CN22.08.2019
(Supplementary) European search report - dispatched on:EP08.10.2021
ClassificationIPC:A61K31/365, A61P37/06
[2021/45]
CPC:
A61K31/365 (EP); A61K31/585 (CN); A61K31/343 (US);
A61K9/20 (US); A61P31/18 (CN); A61P37/06 (EP,CN)
Former IPC [2020/52]A61K31/585, A61P37/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/52]
TitleGerman:ANWENDUNG VON (5R)-5-HYDROXYTRIPTOLID ZUR HERSTELLUNG VON ARZNEIMITTELN[2020/52]
English:APPLICATION OF (5R)-5-HYDROXYTRIPTOLIDE IN PREPARATION OF DRUGS[2020/52]
French:APPLICATION DE (5R)-5-HYDROXYTRIPTOLIDE DANS LA PRÉPARATION DE MÉDICAMENTS[2020/52]
Entry into regional phase10.09.2020Translation filed 
10.09.2020National basic fee paid 
10.09.2020Search fee paid 
10.09.2020Designation fee(s) paid 
10.09.2020Examination fee paid 
Examination procedure10.09.2020Examination requested  [2020/52]
26.04.2022Amendment by applicant (claims and/or description)
05.10.2023Despatch of a communication from the examining division (Time limit: M04)
02.02.2024Reply to a communication from the examining division
Fees paidRenewal fee
10.09.2020Renewal fee patent year 03
20.12.2021Renewal fee patent year 04
22.12.2022Renewal fee patent year 05
18.12.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search   [ ] - No further relevant documents disclosed
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.